Last Updated : February 27, 2012
Details
FilesGeneric Name:
Rivaroxaban
Project Status:
Complete
Therapeutic Area:
Deep-vein thrombosis without symptomatic pulmonary embolism
Manufacturer:
Bayer Inc.
Call for patient/clinician input open:
Brand Name:
Xarelto
Project Line:
Reimbursement Review
Project Number:
SR0271-000
Call for patient/clinician input closed:
NOC Status at Filing:
Post NOC
Performance Metric:
N/A — Predated performance metrics
Submission Type:
Initial
Indications:
Deep-Vein Thrombosis (treatment), without Symptomatic Pulmonary Embolism
Recommendation Type:
List with clinical criteria and/or conditions
Final Recommendation:
Files
Last Updated : February 27, 2012